Skip to main content
. Author manuscript; available in PMC: 2014 Oct 3.
Published in final edited form as: Neuropharmacology. 2011 Dec 28;62(0):1916–1927. doi: 10.1016/j.neuropharm.2011.12.022

Figure 6.

Figure 6

24hr kaolin intake (A), chow intake (B), and body weight change (C) following an acute intraparenchymal CeA administration of exendin-4 (0.05μg/100nl) or vehicle. In a two-bottle CTA learning paradigm, CeA administration of exendin-4 produced a CTA when compared to vehicle injections (D). Data are mean ± SEM, * = p < 0.05 vs. vehicle.